Jubilant stock has had an impressive run this year, with the stock price nearly doubling year-to-date in 2017.
Jubilant stock has had an impressive run this year, with the stock price nearly doubling year-to-date in 2017.
Wipro has outperformed peers within the BFSI vertical with double-digit revenue growth (14% y-o-y in 2Q18) and strong deal wins.…
Discussions on Motherson Sumi are often focused on the domestic wiring harness business, its larger subsidiaries SMP, SMR and now…
Company confident of demand picking up; while it has ability to drive through tech cycles, high base and valuations limit…
Business momentum on the retail side remained strong for Phoenix Mills’ main malls with overall consumption growing by 19% (partly…
FY18/19 Ebitda estimates down 11/7%; valuation too high vis-a-vis past record
India’s car industry appears to be at an inflection point. Car sales tend to accelerate after the penetration rate passes…
The Aditya Birla Group will hold the rights to acquire an additional 9.5% stake from Vodafone within 3 years post…
In a recent earnings call, the company’s management indicated that its working capital will look stretched at FY18-end.
The media regulator has is- sued draft tariff guidelines that will be applicable from April 2017 onwards.
We expect Maruti to report a strong Q2, reporting margin expansion of 90-100 bps q-o-q. While YEN is adverse, the…
Q2FY17 is likely to be a better quarter for banks compared to the past three quarters, given two main drivers—the…
New banks are a rare breed in India. IDFC Bank (IDFCBK), carved out of its parent, infrastructure lender IDFC Ltd,…
What the implications of growing acceptance/prospects of EVs (Electric vehicles) on JLR are is one of the most frequent questions…
In our view the market seems to be pricing an accelerated deployment of 4G by incumbent telcos post Jio 4G…
What are the implications of growing acceptance / prospects of EVs (Electric vehicles) on JLR is one of the most…
Companies with emerging focus on chronic therapies are likely to sustain India growth; lower US exposure limits US FDA risk.
While acquiring the right to operate at Abbot Point Coal terminal represents a risk-free profit stream without capital investment, it…